Why the study?
Are older HMO patients with depression treated differently than younger patients in terms of diagnosis, specialty care, and pharmacotherapy?
Are older HMO patients with depression treated differently than younger patients in terms of diagnosis, specialty care, and pharmacotherapy?
Older patients with depression in HMOs receive different care patterns, including fewer SSRIs and more benzodiazepines, highlighting a need for improved psychotropic medication management.
No takes yet. Share an insight, caveat, or question.
Highlights potential age disparities in HMO depression care; leaves open causality and optimal management.
Bartels et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: